166 related articles for article (PubMed ID: 25549347)
1. Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Imperiale A; Bahougne T; Goichot B; Bachellier P; Taïeb D; Namer IJ
Clin Nucl Med; 2015 Aug; 40(8):682-4. PubMed ID: 25549347
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/CT imaging of insulinoma revisited.
Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
[TBL] [Abstract][Full Text] [Related]
3. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Tessonnier L; Sebag F; Ghander C; De Micco C; Reynaud R; Palazzo FF; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
J Clin Endocrinol Metab; 2010 Jan; 95(1):303-7. PubMed ID: 19915018
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of
Nakuz TS; Berger E; El-Rabadi K; Wadsak W; Haug A; Hacker M; Karanikas G
Anticancer Res; 2018 Jan; 38(1):353-358. PubMed ID: 29277794
[TBL] [Abstract][Full Text] [Related]
5. Early
Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
[TBL] [Abstract][Full Text] [Related]
6. Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Detour J; Pierre A; Boisson F; Kreutter G; Lavaux T; Namer IJ; Kessler L; Brasse D; Marchand P; Imperiale A
J Nucl Med; 2017 Jan; 58(1):36-41. PubMed ID: 27609787
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
van Beek AP; de Heide LJ; van Ginkel B; Slart RH; van der Horst-Schrivers AN; Boellaard R; de Vries EG; Noordzij W; Glaudemans AW
Clin Nucl Med; 2017 Mar; 42(3):163-168. PubMed ID: 28005639
[TBL] [Abstract][Full Text] [Related]
8. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
10. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract][Full Text] [Related]
11. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography.
Kauhanen S; Seppänen M; Nuutila P
J Clin Oncol; 2008 Nov; 26(32):5307-8; author reply 5308-9. PubMed ID: 18854556
[No Abstract] [Full Text] [Related]
12. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Sood A; Basher RK; Kang M; Shukla J; Behera A; Walia R; Nada R; Mittal BR; Bhattacharya A
Clin Nucl Med; 2019 Jul; 44(7):e428-e430. PubMed ID: 31107750
[TBL] [Abstract][Full Text] [Related]
14. Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Imperiale A; Addeo P; Averous G; Namer IJ; Bachellier P
J Clin Endocrinol Metab; 2013 Jul; 98(7):2643-4. PubMed ID: 23671317
[No Abstract] [Full Text] [Related]
15. Value of
Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
[TBL] [Abstract][Full Text] [Related]
16. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
17. O-(2-
Imperiale A; Boisson F; Kreutter G; Goichot B; Namer IJ; Bachellier P; Laquerriere P; Kessler L; Marchand P; Brasse D
Nucl Med Biol; 2017 Oct; 53():21-28. PubMed ID: 28793277
[TBL] [Abstract][Full Text] [Related]
18.
Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
[TBL] [Abstract][Full Text] [Related]
19. Epiglottic Squamous Cell Carcinoma Showing Unexpected 18F-FDOPA Uptake on PET/CT Investigation.
Dietemann S; Debry C; Onea A; Namer IJ; Imperiale A
Clin Nucl Med; 2015 Jul; 40(7):e370-1. PubMed ID: 26018705
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDOPA: a multiple-target molecule.
Minn H; Kauhanen S; Seppänen M; Nuutila P
J Nucl Med; 2009 Dec; 50(12):1915-8. PubMed ID: 19910423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
